Sivik Global Healthcare’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-32,802
| Closed | -$874K | – | 64 |
|
|
2018
Q3 | $874K | Buy |
32,802
+17,802
| +119% | +$474K | 0.31% | 59 |
|
|
2018
Q2 | $567K | Buy |
+15,000
| New | +$567K | 0.22% | 61 |
|
|
2018
Q1 | – | Sell |
-40,000
| Closed | -$1.95M | – | 71 |
|
|
2017
Q4 | $1.95M | Buy |
40,000
+15,000
| +60% | +$730K | 0.72% | 60 |
|
|
2017
Q3 | $1.35M | Sell |
25,000
-5,000
| -17% | -$270K | 0.46% | 67 |
|
|
2017
Q2 | $1.69M | Buy |
+30,000
| New | +$1.69M | 0.62% | 56 |
|
|
2016
Q1 | – | Sell |
-22,500
| Closed | -$1.16M | – | 68 |
|
|
2015
Q4 | $1.16M | Sell |
22,500
-7,500
| -25% | -$386K | 0.55% | 56 |
|
|
2015
Q3 | $1.28M | Hold |
30,000
| – | – | 0.62% | 52 |
|
|
2015
Q2 | $1.37M | Buy |
30,000
+5,000
| +20% | +$228K | 0.47% | 60 |
|
|
2015
Q1 | $949K | Buy |
+25,000
| New | +$949K | 0.32% | 74 |
|
|
2014
Q2 | – | Sell |
-30,600
| Closed | -$793K | – | 78 |
|
|
2014
Q1 | $793K | Buy |
30,600
+5,600
| +22% | +$145K | 0.5% | 64 |
|
|
2013
Q4 | $644K | Buy |
+25,000
| New | +$644K | 0.46% | 55 |
|